British Journal of Cancer - Table of Contents alert Volume 109 Issue 7

TABLE OF CONTENTS Volume 109, Issue 7 (1711-2026) Published online 1 October 2013 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Erratum Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press?  Leukaemia in young children in the vicinity of British nuclear power plants: a case?control study J F Bithell, M F G Murphy et al.  Clinical Studies Top A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer K Kruczek, M Ratterman, K Tolzien, S Sulo, T M Lestingi and C Nabhan Br J Cancer 2013 109: 1711-1716; advance online publication, September 5, 2013; 10.1038/bjc.2013.530 Abstract | Full Text Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials A L Cesne, I Judson, R Maki, F Grosso, S Schuetze, M V Mehren, S P Chawla, G D Demetri, A Nieto, A Tanovic and J-Y Blay Br J Cancer 2013 109: 1717-1724; advance online publication, September 10, 2013; 10.1038/bjc.2013.524 Abstract | Full Text A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer R K Kelley, J Hwang, M J M Magbanua, L Watt, J H Beumer, S M Christner, S Baruchel, B Wu, L Fong, B M Yeh, A P Moore, A H Ko, W M Korn, S Rajpal, J W Park, M A Tempero, A P Venook and E K Bergsland Br J Cancer 2013 109: 1725-1734; advance online publication, September 10, 2013; 10.1038/bjc.2013.553 Abstract | Full Text Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer F Joulain, I Proskorovsky, C Allegra, J Tabernero, M Hoyle, S U Iqbal and E Van Cutsem Br J Cancer 2013 109: 1735-1743; advance online publication, September 17, 2013; 10.1038/bjc.2013.523 Abstract | Full Text Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030) S G Louie, B Ely, H-J Lenz, K S Albain, C Gotay, D Coleman, D Raghavan, A F Shields, P J Gold and C D Blanke Br J Cancer 2013 109: 1744-1749; advance online publication, September 10, 2013; 10.1038/bjc.2013.517 Abstract | Full Text Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma M Gilabert, M Provansal, M Cappiello, Y Walz, N Salem, C Tarpin, S Brunelle, J Thomassin and G Gravis Br J Cancer 2013 109: 1750-1754; advance online publication, September 17, 2013; 10.1038/bjc.2013.516 Abstract | Full Text Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma M Santoni, U De Giorgi, R Iacovelli, A Conti, L Burattini, L Rossi, S Luca Burgio, R Berardi, G Muzzonigro, E Cortesi, D Amadori and S Cascinu Br J Cancer 2013 109: 1755-1759; advance online publication, September 5, 2013; 10.1038/bjc.2013.522 Abstract | Full Text Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)? M Takano, H Ochi, Y Takei, M Miyamoto, Y Hasumi, Y Kaneta, K Nakamura, A Kurosaki, T Satoh, H Fujiwara, S Nagao, K Furuya, H Yokota, K Ito, T Minegishi, H Yoshikawa, K Fujiwara and M Suzuki Br J Cancer 2013 109: 1760-1765; advance online publication, September 3, 2013; 10.1038/bjc.2013.521 Abstract | Full Text hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy F Carozzi, C B Visioli, M Confortini, A Iossa, P Mantellini, E Burroni and M Zappa Br J Cancer 2013 109: 1766-1774; advance online publication, September 5, 2013; 10.1038/bjc.2013.519 Abstract | Full Text Translational Therapeutics Top Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model M D Reed, C S Tellez, M J Grimes, M A Picchi, M Tessema, Y S Cheng, T H March, P J Kuehl and S A Belinsky Br J Cancer 2013 109: 1775-1781; advance online publication, September 17, 2013; 10.1038/bjc.2013.575 Abstract | Full Text Molecular Diagnostics Top The interaction between prognostic and pharmacodynamic biomarkers L Bouranis, M Sperrin, A Greystoke, C Dive and A G Renehan Br J Cancer 2013 109: 1782-1785; advance online publication, September 3, 2013; 10.1038/bjc.2013.527 Abstract | Full Text Targeting EGFR and PI3K pathways in ovarian cancer S Glaysher, L M Bolton, P Johnson, N Atkey, M Dyson, C Torrance and I A Cree Br J Cancer 2013 109: 1786-1794; advance online publication, September 10, 2013; 10.1038/bjc.2013.529 Abstract | Full Text PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells W Chien, K L Lee, L W Ding, P Wuensche, H Kato, N B Doan, L Poellinger, J W Said and H P Koeffler Br J Cancer 2013 109: 1795-1804; advance online publication, September 3, 2013; 10.1038/bjc.2013.531 Abstract | Full Text Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis P W Voorneveld, V Stache, R J Jacobs, E Smolders, A I Sitters, A Liesker, K S Korkmaz, S M Lam, N F C C De Miranda, H Morreau, L L Kodach and J C H Hardwick Br J Cancer 2013 109: 1805-1812; advance online publication, August 22, 2013; 10.1038/bjc.2013.486 Abstract | Full Text Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma T M Meniawy, J Creaney, R A Lake and A K Nowak Br J Cancer 2013 109: 1813-1820; advance online publication, August 27, 2013; 10.1038/bjc.2013.504 Abstract | Full Text EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice S Gahr, R Stoehr, E Geissinger, J H Ficker, W M Brueckl, A Gschwendtner, S Gattenloehner, F S Fuchs, C Schulz, R J Rieker, A Hartmann, P Ruemmele and W Dietmaier Br J Cancer 2013 109: 1821-1828; advance online publication, September 3, 2013; 10.1038/bjc.2013.511 Abstract | Full Text Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases G Bouchard, G Bouvette, H Therriault, R Bujold, C Saucier and B Paquette Br J Cancer 2013 109: 1829-1838; advance online publication, September 3, 2013; 10.1038/bjc.2013.502 Abstract | Full Text Detailed analysis of inflammatory cell infiltration in colorectal cancer J P Väyrynen, A Tuomisto, K Klintrup, J Mäkelä, T J Karttunen and M J Mäkinen Br J Cancer 2013 109: 1839-1847; advance online publication, September 5, 2013; 10.1038/bjc.2013.508 Abstract | Full Text Presence of the Coxsackievirus and Adenovirus Receptor (CAR) in human neoplasms: a multitumour array analysis M Reeh, M Bockhorn, D Görgens, M Vieth, T Hoffmann, R Simon, J R Izbicki, G Sauter, U Schumacher and M Anders Br J Cancer 2013 109: 1848-1858; advance online publication, September 10, 2013; 10.1038/bjc.2013.509 Abstract | Full Text The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma A C Klimowicz, P Bose, S K Petrillo, A M Magliocco, J C Dort and N T Brockton Br J Cancer 2013 109: 1859-1866; advance online publication, September 5, 2013; 10.1038/bjc.2013.533 Abstract | Full Text Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia R Ihnatko, C Post and A Blomqvist Br J Cancer 2013 109: 1867-1875; advance online publication, September 3, 2013; 10.1038/bjc.2013.525 Abstract | Full Text Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells P Liu, I S Kumar, S Brown, V Kannappan, P E Tawari, J Z Tang, W Jiang, A L Armesilla, J L Darling and W Wang Br J Cancer 2013 109: 1876-1885; advance online publication, September 5, 2013; 10.1038/bjc.2013.534 Abstract | Full Text Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers A R Green, D G Powe, E A Rakha, D Soria, C Lemetre, C C Nolan, F F T Barros, R D Macmillan, J M Garibaldi, G R Ball and I O Ellis Br J Cancer 2013 109: 1886-1894; advance online publication, September 5, 2013; 10.1038/bjc.2013.528 Abstract | Full Text Epidemiology Top Exogenous hormone use, reproductive history and risk of adult myeloid leukaemia J N Poynter, R Fonstad, C K Blair, M Roesler, J R Cerhan, B Hirsch, P Nguyen and J A Ross Br J Cancer 2013 109: 1895-1898; advance online publication, September 3, 2013; 10.1038/bjc.2013.507 Abstract | Full Text Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma Y Ohno, J Nakashima, Y Nakagami, N Satake, T Gondo, M Ohori, T Hatano and M Tachibana Br J Cancer 2013 109: 1899-1903; advance online publication, September 3, 2013; 10.1038/bjc.2013.512 Abstract | Full Text Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan K Nouso, K Miyahara, D Uchida, K Kuwaki, N Izumi, M Omata, T Ichida, M Kudo, Y Ku, N Kokudo, M Sakamoto, O Nakashima, T Takayama, O Matsui, Y Matsuyama and K Yamamoto the Liver Cancer Study Group of Japan Br J Cancer 2013 109: 1904-1907; advance online publication, September 5, 2013; 10.1038/bjc.2013.542 Abstract | Full Text Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer S Uccella, A Mariani, A H Wang, R A Vierkant, W A Cliby, K Robien, K E Anderson and J R Cerhan Br J Cancer 2013 109: 1908-1913; advance online publication, September 10, 2013; 10.1038/bjc.2013.540 Abstract | Full Text Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case–control study in Italy M Rossi, V Edefonti, M Parpinel, P Lagiou, M Franchi, M Ferraroni, A Decarli, A Zucchetto, D Serraino, L Dal Maso, E Negri and C La Vecchia Br J Cancer 2013 109: 1914-1920; advance online publication, August 6, 2013; 10.1038/bjc.2013.447 Abstract | Full Text Low-dose aspirin use and cancer characteristics: a population-based cohort study F Jonsson, L Yin, C Lundholm, K E Smedby, K Czene and Y Pawitan Br J Cancer 2013 109: 1921-1925; advance online publication, July 25, 2013; 10.1038/bjc.2013.411 Abstract | Full Text Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose–response meta-analysis W Wu, S Kang and D Zhang Br J Cancer 2013 109: 1926-1944; advance online publication, August 1, 2013; 10.1038/bjc.2013.438 Abstract | Full Text Does alcohol increase breast cancer risk in African-American women? Findings from a case–control study U Chandran, G Zirpoli, G Ciupak, S E McCann, Z Gong, K Pawlish, Y Lin, K Demissie, C B Ambrosone and E V Bandera Br J Cancer 2013 109: 1945-1953; advance online publication, September 5, 2013; 10.1038/bjc.2013.513 Abstract | Full Text Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO) A C Pesatori, M Carugno, D Consonni, R J Hung, A Papadoupolos, M T Landi, H Brenner, H Müller, C C Harris, E J Duell, A S Andrew, J R McLaughlin, A G Schwartz, A S Wenzlaff and I Stucker Br J Cancer 2013 109: 1954-1964; advance online publication, September 3, 2013; 10.1038/bjc.2013.506 Abstract | Full Text The latency period of mesothelioma among a cohort of British asbestos workers (1978–2005) G Frost Br J Cancer 2013 109: 1965-1973; advance online publication, August 29, 2013; 10.1038/bjc.2013.514 Abstract | Full Text Prognosis in HIV-infected patients with non-small cell lung cancer K Sigel, K Crothers, R Dubrow, K Krauskopf, J Jao, C Sigel, A Moskowitz and J Wisnivesky Br J Cancer 2013 109: 1974-1980; advance online publication, September 10, 2013; 10.1038/bjc.2013.545 Abstract | Full Text HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis H Carreira, F Coutinho, C Carrilho and N Lunet Br J Cancer 2013 109: 1981-1988; advance online publication, September 12, 2013; 10.1038/bjc.2013.539 Abstract | Full Text Solid cancer incidence other than lung, liver and bone in Mayak workers: 1948–2004 N Hunter, I S Kuznetsova, E V Labutina and J D Harrison Br J Cancer 2013 109: 1989-1996; advance online publication, September 10, 2013; 10.1038/bjc.2013.543 Abstract | Full Text Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case–control study J-B Wang, C C Abnet, W Chen, S M Dawsey, J-H Fan, L-Y Yin, J Yin, J M Major, P R Taylor, Y-L Qiao and N D Freedman Br J Cancer 2013 109: 1997-2004; advance online publication, September 5, 2013; 10.1038/bjc.2013.546 Abstract | Full Text Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study R Erichsen, E Horváth-Puhó, L H Iversen, T L Lash and H T Sørensen Br J Cancer 2013 109: 2005-2013; advance online publication, September 10, 2013; 10.1038/bjc.2013.541 Abstract | Full Text Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis P-H Zahl, K J Jørgensen and P C Gøtzsche Br J Cancer 2013 109: 2014-2019; advance online publication, August 20, 2013; 10.1038/bjc.2013.427 Abstract | Full Text Letters to the Editor Top Comment on ‘Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudes’ – Oncologists must not allow personal attitudes to influence discussions on fertility preservation for cancer survivors N Young, A Leibowitz and R Bowden Br J Cancer 2013 109: 2020; advance online publication, August 13, 2013; 10.1038/bjc.2013.459 Full Text Reply: Comment on ‘Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudes’ – Oncologists must not allow personal attitudes to influence discussions on fertility preservation for cancer survivors E Adams, E Hill and E Watson Br J Cancer 2013 109: 2021-2022; advance online publication, August 13, 2013; 10.1038/bjc.2013.460 Full Text Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma’ Y Ji and S Chen Br J Cancer 2013 109: 2022-2023; advance online publication, August 22, 2013; 10.1038/bjc.2013.497 Full Text Reply: Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma’ – β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs E Pasquier, N Andre, T Trahair and M Kavallaris Br J Cancer 2013 109: 2024-2025; advance online publication, August 22, 2013; 10.1038/bjc.2013.498 Full Text Full Text Erratum Top Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer M Stotz, A Gerger, F Eisner, J Szkandera, H Loibner, A L Ress, P Kornprat, W AlZoughbi, F S Seggewies, C Lackner, T Stojakovic, H Samonigg, G Hoefler and M Pichler Br J Cancer 2013 109: 2026; 10.1038/bjc.2013.591 Full Text Advertisement British Journal of Cancer presents: Web Focus on Lifestyle Lifestyle is now known to contribute significantly to global cancer burdens. We highlight here some recent studies and meta-analyses that identify various factors associated with risk of developing cancer.  Read the articles for FREE  Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.